Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox (Mpox) Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Disclosures
- CAA pathology
- CAA pathogenesis
- CAA prevalence
- CAA diagnosis
- CAA clinical spectrum
- Rare clinical presentations of CAA
- cSAH
- cSAH & CAA: Clinical presentation
- cSAH & CAA: Imaging features
- cSAH & CAA: Outcomes
- Inflammatory CAA
- Inflammatory CAA: Imaging features
- Inflammatory CAA: Plasma and CSF findings
- Inflammatory CAA: Diagnostic criteria
- Inflammatory CAA: Differential diagnoses
- Inflammatory CAA: Treatment & outcome
- Iatrogenic CAA
- Iatrogenic CAA: Aβ transmission
- Iatrogenic CAA: Typical presentation
- Iatrogenic CAA: Diagnositc criteria
- Other presentations of CAA
- Take home messages
Topics Covered
- Cerebral Amyloid Angiopathy (CAA)
- Convexity Subarachnoid Hemorrhage (cSAH)
- Inflammatory CAA
- Iatrogenic CAA
- Other presentations of CAA
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Raposo, N. (2024, September 30). Rare clinical presentations of cerebral amyloid angiopathy [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 21, 2024, from https://doi.org/10.69645/QCYK2084.Export Citation (RIS)
Publication History
Financial Disclosures
- - Research grants: Fulbright Scholarship, Arthur Sachs Scholarship from the Harvard University committee, Philippe Foundation - Consultant fees: Novartis - Speaker honoraria: Bristol-Myers Squibb
Other Talks in the Series: Cerebral Amyloid Angiopathy (CAA)
Transcript
Please wait while the transcript is being prepared...
0:00
Hi everyone. I'm Nicolas Raposo.
I'm a stroke neurologist
and coordinator of
Stroke Research
Program on CAA and
Cerebral Small Vessel Diseases
at Toulouse University
Hospital in France.
The topic of my presentation is
rare clinical
presentations of CAA.
0:22
Here are my disclosures,
which are not
related to the present topic
except for research grants.
0:30
Cerebral amyloid angiopathy,
designated as CAA
during this talk,
is a common age-related
cerebral small vessel
disease characterized by
a beta-amyloid deposition within
the wall of small cortical
and leptomeningeal vessels.
0:48
This amyloid deposition may lead
to various forms of cerebral
vascular dysfunction,
including blood-brain
barrier disruption,
impaired cerebrovascular
reactivity,
impaired perivascular drainage.
There's also various forms of
brain injury including
hemorrhagic damages,
this includes lobar
intracerebral hemorrhage,
microbleeds, convexity
subarachnoid hemorrhage,
cortical superficial siderosis.
May include ischemic injury,
such as white matter
hyperintensities,
small acute ischemic
lesions, and cortical
micro-infarcts, and also
perivascular inflammations.
These various forms of
brain injury may account
for various clinical
presentations
including stroke symptoms,
transient focal
neurological episodes,
seizures, encephalopathy,
cognitive impairment,
and dementia.